313 related articles for article (PubMed ID: 16928871)
1. The Chk1/Cdc25A pathway as activators of the cell cycle in neuronal death induced by camptothecin.
Zhang Y; Qu D; Morris EJ; O'Hare MJ; Callaghan SM; Slack RS; Geller HM; Park DS
J Neurosci; 2006 Aug; 26(34):8819-28. PubMed ID: 16928871
[TBL] [Abstract][Full Text] [Related]
2. Pim-1 kinase as activator of the cell cycle pathway in neuronal death induced by DNA damage.
Zhang Y; Parsanejad M; Huang E; Qu D; Aleyasin H; Rousseaux MW; Gonzalez YR; Cregan SP; Slack RS; Park DS
J Neurochem; 2010 Jan; 112(2):497-510. PubMed ID: 19895669
[TBL] [Abstract][Full Text] [Related]
3. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control.
Demidova AR; Aau MY; Zhuang L; Yu Q
J Biol Chem; 2009 Feb; 284(7):4132-9. PubMed ID: 19060337
[TBL] [Abstract][Full Text] [Related]
4. The regulatory beta-subunit of protein kinase CK2 accelerates the degradation of CDC25A phosphatase through the checkpoint kinase Chk1.
Kreutzer J; Guerra B
Int J Oncol; 2007 Nov; 31(5):1251-9. PubMed ID: 17912454
[TBL] [Abstract][Full Text] [Related]
5. Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents.
Xiao Z; Chen Z; Gunasekera AH; Sowin TJ; Rosenberg SH; Fesik S; Zhang H
J Biol Chem; 2003 Jun; 278(24):21767-73. PubMed ID: 12676925
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine.
Sampath D; Shi Z; Plunkett W
Mol Pharmacol; 2002 Sep; 62(3):680-8. PubMed ID: 12181445
[TBL] [Abstract][Full Text] [Related]
7. Cdc25A Is a Critical Mediator of Ischemic Neuronal Death
Iyirhiaro GO; Im DS; Boonying W; Callaghan SM; During MJ; Slack RS; Park DS
J Neurosci; 2017 Jul; 37(28):6729-6740. PubMed ID: 28607169
[TBL] [Abstract][Full Text] [Related]
8. Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy.
Xiao Z; Xue J; Sowin TJ; Zhang H
Mol Cancer Ther; 2006 Aug; 5(8):1935-43. PubMed ID: 16928813
[TBL] [Abstract][Full Text] [Related]
9. SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase.
Jin J; Shirogane T; Xu L; Nalepa G; Qin J; Elledge SJ; Harper JW
Genes Dev; 2003 Dec; 17(24):3062-74. PubMed ID: 14681206
[TBL] [Abstract][Full Text] [Related]
10. Differential impact of diverse anticancer chemotherapeutics on the Cdc25A-degradation checkpoint pathway.
Agner J; Falck J; Lukas J; Bartek J
Exp Cell Res; 2005 Jan; 302(2):162-9. PubMed ID: 15561098
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints.
Zhao H; Watkins JL; Piwnica-Worms H
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14795-800. PubMed ID: 12399544
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest.
Nguyen DX; Westbrook TF; McCance DJ
J Virol; 2002 Jan; 76(2):619-32. PubMed ID: 11752153
[TBL] [Abstract][Full Text] [Related]
13. Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism.
Uto K; Inoue D; Shimuta K; Nakajo N; Sagata N
EMBO J; 2004 Aug; 23(16):3386-96. PubMed ID: 15272308
[TBL] [Abstract][Full Text] [Related]
14. Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents.
Park DS; Morris EJ; Padmanabhan J; Shelanski ML; Geller HM; Greene LA
J Cell Biol; 1998 Oct; 143(2):457-67. PubMed ID: 9786955
[TBL] [Abstract][Full Text] [Related]
15. Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics.
Chen Z; Xiao Z; Gu WZ; Xue J; Bui MH; Kovar P; Li G; Wang G; Tao ZF; Tong Y; Lin NH; Sham HL; Wang JY; Sowin TJ; Rosenberg SH; Zhang H
Int J Cancer; 2006 Dec; 119(12):2784-94. PubMed ID: 17019715
[TBL] [Abstract][Full Text] [Related]
16. Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding.
Chen MS; Ryan CE; Piwnica-Worms H
Mol Cell Biol; 2003 Nov; 23(21):7488-97. PubMed ID: 14559997
[TBL] [Abstract][Full Text] [Related]
17. DNA damage-induced degradation of Cdc25A does not lead to inhibition of Cdk2 activity in mouse embryonic stem cells.
Koledova Z; Kafkova LR; Krämer A; Divoky V
Stem Cells; 2010 Mar; 28(3):450-61. PubMed ID: 20104581
[TBL] [Abstract][Full Text] [Related]
18. Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation.
Chang WL; Hsu LC; Leu WJ; Chen CS; Guh JH
Oncotarget; 2015 Nov; 6(37):39806-20. PubMed ID: 26447757
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Chk1-Cdc25A-cyclin A/CDK2 pathway in simvastatin induced S-phase cell cycle arrest and apoptosis in multiple myeloma cells.
Tu YS; Kang XL; Zhou JG; Lv XF; Tang YB; Guan YY
Eur J Pharmacol; 2011 Nov; 670(2-3):356-64. PubMed ID: 21958871
[TBL] [Abstract][Full Text] [Related]
20. CK1ε targets Cdc25A for ubiquitin-mediated proteolysis under normal conditions and in response to checkpoint activation.
Piao S; Lee SJ; Xu Y; Gwak J; Oh S; Park BJ; Ha NC
Cell Cycle; 2011 Feb; 10(3):531-7. PubMed ID: 21252624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
